139 related articles for article (PubMed ID: 37259544)
21. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
Hanifin J; Gupta AK; Rajagopalan R
Br J Dermatol; 2002 Sep; 147(3):528-37. PubMed ID: 12207596
[TBL] [Abstract][Full Text] [Related]
22. Clinical and instrumental evaluation of the efficacy of an emollient cream and a cleansing cream in the management of mild to moderate adulthood atopic dermatitis.
Cristaudo A; Lupi F; Mariano M; Cianchini G; De Rocco M; De Pità O
G Ital Dermatol Venereol; 2018 Dec; 153(6):855-859. PubMed ID: 30518177
[TBL] [Abstract][Full Text] [Related]
23. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
24. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
25. Patient and caregiver preferences on treatment attributes for atopic dermatitis.
Ervin C; Crawford R; Evans E; Feldman SR; Zeichner J; Zielinski MA; Cappelleri JC; DiBonaventura M; Takiya L; Myers DE
J Dermatolog Treat; 2022 Jun; 33(4):2225-2233. PubMed ID: 34264145
[TBL] [Abstract][Full Text] [Related]
26. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
27. Patients' preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most.
Schaarschmidt ML; Kromer D; Wellmann P; Peitsch WK; Kromer C
J Dermatolog Treat; 2024 Dec; 35(1):2308682. PubMed ID: 38297480
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of an alkaline topical treatment in patients with mild atopic dermatitis.
Jurecek L; Rajcigelova T; Kozarova A; Werner T; Vormann J; Kolisek M
J Cosmet Dermatol; 2021 Sep; 20(9):2824-2831. PubMed ID: 33448109
[TBL] [Abstract][Full Text] [Related]
29. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
[TBL] [Abstract][Full Text] [Related]
30. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
31. Assessing patients' characteristics and treatment patterns among children with atopic dermatitis.
Geat D; Giovannini M; Barlocco G; Pertile R; Pace M; Mori F; Novembre E; Girolomoni G; Cristofolini M; Baldo E
Ital J Pediatr; 2021 Apr; 47(1):92. PubMed ID: 33863347
[TBL] [Abstract][Full Text] [Related]
32. "His first word was 'cream'." The burden of treatment in pediatric atopic dermatitis-A mixed methods study.
O'Connor C; Dhonncha EN; Murphy M
Dermatol Ther; 2022 Mar; 35(3):e15273. PubMed ID: 34914164
[TBL] [Abstract][Full Text] [Related]
33. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual double-blind, multi-center trial.
Marini A; Reinelt K; Krutmann J; Bilstein A
Skin Pharmacol Physiol; 2014; 27(2):57-65. PubMed ID: 23949258
[TBL] [Abstract][Full Text] [Related]
34. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
Patrizi A; Raone B; Raboni R; Neri I
G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
[TBL] [Abstract][Full Text] [Related]
36. Duration of topical therapy in the maintenance of atopic dermatitis remission in pediatric age.
Pecoraro L; Florile M; Piazza M; Comberiati P; Clemente M; Tadiotto E; Pietrobelli A; Piacentini G
Minerva Pediatr (Torino); 2021 Aug; 73(4):294-300. PubMed ID: 29968448
[TBL] [Abstract][Full Text] [Related]
37. Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Schlessinger J; Shepard JS; Gower R; Su JC; Lynde C; Cha A; Ports WC; Purohit V; Takiya L; Werth JL; Zang C; Vlahos B;
Am J Clin Dermatol; 2020 Apr; 21(2):275-284. PubMed ID: 32212104
[TBL] [Abstract][Full Text] [Related]
38. The importance of vehicle properties to patients with atopic dermatitis.
Trookman NS; Rizer RL; Ho ET; Ford RO; Gotz V
Cutis; 2011 Jul; 88(1 Suppl):13-7. PubMed ID: 21919229
[TBL] [Abstract][Full Text] [Related]
39. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis.
Draelos ZD
J Cosmet Dermatol; 2011 Sep; 10(3):185-8. PubMed ID: 21896129
[TBL] [Abstract][Full Text] [Related]
40. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
